Clinical Effect of Syp. Kankasava in Patients With COVID-19: A Preliminary Observational Study
Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS) · 05.11.2026 · 2 (10)
DOI: 10.68108/intemed.v2.i10.22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS), online erschienen am 05.11.2026. Verfasst von Dr. Abhijit M Ahire und 2 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
COVID-19 commonly presents with cough and respiratory distress. Syp. Kankasava is a classical Ayurvedic fermented formulation traditionally used for respiratory complaints. However, direct clinical evidence for its use in COVID-19 remains limited, and it should not replace evidence-based COVID-19 treatment or oxygen support. Objective: To describe the change in cough, breathlessness, and recorded oxygen-related clinical score among COVID-19 patients treated with Syp. Kankasava.
Zitieren
APA
Ahire, D. A. M., Kulkarni, D. P. V., & Perke, D. B. M. (2026). Clinical Effect of Syp. Kankasava in Patients With COVID-19: A Preliminary Observational Study. Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS), 2(10). https://doi.org/10.68108/intemed.v2.i10.22
Vancouver
Ahire DAM, Kulkarni DPV, Perke DBM. Clinical Effect of Syp. Kankasava in Patients With COVID-19: A Preliminary Observational Study. Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS). 2026;2(10). doi:10.68108/intemed.v2.i10.22
BibTeX
@article{Ahire2026,
author = {Ahire, Dr. Abhijit M and Kulkarni, Dr. Prasad V. and Perke, Dr. Bhaskar M.},
title = {Clinical Effect of Syp. Kankasava in Patients With COVID-19: A Preliminary Observational Study},
journal = {Intemed International Journal of Research in Integrated Medical Sciences (IJ-RIMS)},
year = {2026},
volume = {2},
number = {10},
doi = {10.68108/intemed.v2.i10.22}
}
EUVIMED